Finance

Lists
NUZ:ASX
Neurizon Therapeutics Ltd
A$0.078
-8.24%
(-0.0070) 1D
Sep 10, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NUZ...
Open
A$0.08
High
A$0.09
Low
A$0.08
Mkt. cap
57.77M
Avg. vol.
650.27K
Volume
0.00
52-wk high
A$0.16
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
791.65M
No. of employees
52
Open
A$0.08
High
A$0.09
Low
A$0.08
Mkt. cap
57.77M
Avg. vol.
650.27K
Volume
0.00
52-wk high
A$0.16
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
791.65M
No. of employees
52
News stories
From web sources and news partners
About Neurizon Therapeutics Ltd
CEO-
Employees52
Founded2000
Headquarters-
SectorPharmaceutical industry
Websiteneurizon.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.99M
2.99M
5.81M
5.81M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.12M
4.12M
6.40M
6.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.40M
1.40M
1.73M
1.73M
Operating expense
5.70M
5.70M
8.17M
8.17M
Total operating expenses
5.70M
5.70M
8.17M
8.17M
Operating income
-2.72M
-2.72M
-2.37M
-2.37M
Other non operating income
-
-
-
-
EBT including unusual items
-2.77M
-2.77M
-2.59M
-2.59M
EBT excluding unusual items
-2.77M
-2.77M
-2.59M
-2.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.77M
-2.77M
-2.59M
-2.59M
Net profit margin
-92.70%
-92.70%
-44.66%
-44.66%
Earnings per share
-
-
-
-
Interest and investment income
11.89K
11.89K
80.00K
80.00K
Interest expense
-63.39K
-63.39K
-305.23K
-305.23K
Net interest expenses
-51.50K
-51.50K
-225.23K
-225.23K
Depreciation and amortization charges
359.00
359.00
642.00
642.00
EBITDA
-2.72M
-2.72M
-2.37M
-2.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps